Developed through controlled breeding and selection, our high-CBD genetics are designed for stability, uniformity, and compliance with emerging medical frameworks. These cultivars prioritize cannabinoid consistency and agronomic reliability, supporting future pharmaceutical and therapeutic applications within regulated markets.